中達集團控股(00139.HK):主要股東陳湘如已減持6.2億股
格隆匯10月2日丨中達集團控股(00139.HK)公佈,2019年8月16日,公司主要股東陳湘如向線上權益披露系統發出通知書,彼於2019年8月14日出售約6.20億股公司普通股,平均價格為每股股份0.0850港元。
緊接出售事項前,陳湘如於約26.86億股股份中擁有權益,佔公司已發行股本總數約18.25%。緊隨出售事項後,陳湘如於約20.66億股股份中擁有權益,佔公司已發行股本總數約14.03%。
公司並不知悉陳湘如自出售事項以來的任何進一步持股量變動。公告日期,陳湘如仍為公司主要股東。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.